2025-07-29 - Analysis Report
Okay, here's the analysis of Hims & Hers Health Inc (HIMS), incorporating the provided data.

## HIMS Analysis Report

**Ticker:** HIMS
**Company Name:** Hims & Hers Health Inc
**Description:** Hims & Hers Health Inc. is a telehealth company offering personalized health and wellness products and services directly to consumers.

### 1. Performance vs. S&P 500 (VOO)

**Key Metrics:**

*   **HIMS Cumulative Return:** 225.46%
*   **VOO Cumulative Return:** 68.22%
*   **Absolute Divergence (Current):** 151.5
*   **Divergence Range:** Max 288.9, Min -88.4
*   **Relative Divergence:** 63.6

**Analysis:**

HIMS has significantly outperformed the S&P 500 (VOO) over the observed period. The cumulative return difference is substantial (151.5%). The relative divergence of 63.6 indicates that HIMS's performance is in the upper range of its historical outperformance relative to the S&P 500. However, keep in mind that relative divergence is just the rank, not an absolute value.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
| :----------- | :------ | :------ | :------ | :---- | :----- |
| 2019-2021  | -46.0%  | 51.0% | -84.0%  | -0.0  | 1.5   |
| 2020-2022  | -15.0%  | 72.1% | -17.0%  | -0.0  | 1.4   |
| 2021-2023  | -51.0%  | 72.1% | -69.0%  | -0.1  | 2.0   |
| 2022-2024  | 127.0% | 78.4% | 101.0% | -0.1  | 5.4   |
| 2023-2025  | 221.0% | 78.4% | 169.0% | -0.1  | 13.1   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows highly variable performance across different periods, with significant losses in the early periods and substantial gains in the later periods. This volatility suggests the stock's performance is highly sensitive to market conditions and company-specific developments.
*   **MDD:** The Maximum Drawdown (MDD) consistently exceeds 50%, indicating high risk and significant potential for losses.
*   **Alpha:** Alpha is predominantly negative in the earlier periods, improving significantly to positive values in the recent periods. This suggests that HIMS has started to outperform its benchmark in recent years.
*   **Beta:** Beta is consistently near zero, suggesting minimal systematic risk relative to the market. This is unusual and might indicate that HIMS's returns are not strongly correlated with the broader market.
*   **Cap(B):** Market capitalization has increased significantly, especially in the most recent period, indicating substantial growth in company size and investor confidence.

### 2. Recent Price Action

**Key Metrics:**

*   **Current Price:** $58.68
*   **Previous Close:** $57.65
*   **Price Change:** 1.79%
*   **5-Day Moving Average:** $56.336
*   **20-Day Moving Average:** $51.1866
*   **60-Day Moving Average:** $52.9957

**Analysis:**

The stock is trading above all three moving averages (5, 20, and 60 days), indicating a short-term and intermediate-term uptrend.  The recent price change of 1.79% suggests positive momentum.

### 3. Technical Indicators & Expected Return

**Key Metrics:**

*   **Market Risk Indicator (MRI):** 0.3286 (Low Risk)
*   **RSI:** 66.07 (Approaching overbought territory)
*   **PPO:** 2.15
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Delta Previous Relative Divergence:** 9.9 (+): Short-term upward trend
*   **Expected Return:** -11.5% (Long-term, vs. S&P 500)

**Analysis:**

*   The MRI suggests low market risk.
*   The RSI is approaching overbought territory, which might signal a potential pullback.
*   The PPO is positive, supporting the upward trend.
*   The Hybrid Signal indicates a cautious buy signal, recommending 80% cash allocation towards the stock.
*   The recent increase in relative divergence suggests short-term upward momentum.
*   The negative expected return (-11.5%) suggests that, from the current price level, long-term returns may underperform the S&P 500.

**Important Note:** The price change of 1.79% is noteworthy, but without more context on the typical daily volatility of HIMS, it's difficult to say definitively if this represents a significant "sudden" move requiring special consideration.
4.  Recent News & Significant Events

    \[2025-07-25] - Hims & Hers Health Inc (HIMS) has recently made headlines due to major business developments, regulatory changes, or market events. (Source: Example News)
    \[2025-07-29] - Analysts are discussing Hims & Hers Health Inc's (HIMS) recent performance and its outlook in the context of industry trends and global economic factors. (Source: Example Finance)
    \[2025-07-27] - Hims & Hers Health Inc (HIMS)'s stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions. (Source: Example Markets)
    \[2025-07-28] - Market experts highlight both risks and opportunities for Hims & Hers Health Inc (HIMS), advising investors to monitor recent news and company announcements. (Source: Example Analyst)
    Please consider these recent developments in your overall analysis.

    Analysis:

    *   The news indicates that there are significant recent developments, regulatory changes, or market events that are affecting HIMS.
    *   Analysts are actively discussing HIMS's performance, which suggests that the company is under scrutiny and is subject to market analysis.
    *   The stock has shown notable volatility, which could be due to earnings reports, executive actions, or other news events.
    *   Market experts are advising investors to monitor recent news and company announcements.

### 5. Recent Earnings Analysis:

| Date       | EPS  | Revenue    |
| :---------- | :--- | :--------- |
| 2025-05-05 | 0.22 | $0.59B    |
| 2024-11-04 | 0.35 | $0.40B    |
| 2024-08-05 | 0.06 | $0.32B    |
| 2024-05-06 | 0.05 | $0.28B    |
| 2025-05-05 | 0.05 | $0.28B    |

**Analysis:**

*   **EPS:** Earnings per share (EPS) shows a general upward trend. The EPS has significantly improved over the quarters, with a recent peak at 0.35 followed by a slight decrease to 0.22.
*   **Revenue:** Revenue has consistently increased over the quarters, indicating growth in the company's sales. The revenue has more than doubled from $0.28B to $0.59B.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
| :----------- | :------ | :------------ |
| 2025-03-31 | $0.59B  | 73.50%      |
| 2024-12-31 | $0.48B  | 76.81%      |
| 2024-09-30 | $0.40B  | 79.16%      |
| 2024-06-30 | $0.32B  | 81.30%      |
| 2024-03-31 | $0.28B  | 82.36%      |

**Capital and Profitability:**

| Quarter      | Equity  | ROE   |
| :----------- | :------ | :---- |
| 2025-03-31 | $0.55B  | 9.01% |
| 2024-12-31 | $0.48B  | 5.46% |
| 2024-09-30 | $0.44B  | 17.18% |
| 2024-06-30 | $0.36B  | 3.67% |
| 2024-03-31 | $0.34B  | 3.23% |

**Analysis:**

*   **Revenue and Profitability:**
    *   Revenue has been consistently increasing over the past five quarters, from $0.28B to $0.59B, indicating strong top-line growth.
    *   Profit margin has decreased slightly from 82.36% to 73.50% over the same period. While still high, the decreasing trend could indicate increasing costs or changing pricing strategies.
*   **Capital and Profitability:**
    *   Equity has generally increased from $0.34B to $0.55B, reflecting retained earnings and potentially new capital infusions.
    *   Return on Equity (ROE) has fluctuated, with a peak at 17.18% in 2024-09-30 and a recent value of 9.01%. The ROE indicates how effectively the company is using equity to generate profits.

### 7. Overall Summary

Hims & Hers Health Inc. (HIMS) has shown significant outperformance compared to the S&P 500 (VOO), but also exhibits considerable volatility. Recent price action is positive, supported by moving averages, but the RSI suggests the stock may be approaching overbought conditions. The MRI indicates a low-risk environment. Recent earnings and revenue growth are encouraging, though profit margins have seen a slight decline.  While the Hybrid Signal suggests a cautious buy, the negative expected return indicates potential underperformance relative to the S&P 500 over the long term *from the current price*. Recent news indicates active market events that could influence the stock.

**Recommendation:**

Based on this analysis, a cautious approach is warranted. Investors should carefully monitor news and earnings reports, and be aware of the potential for volatility. The stock may be suitable for those with a higher risk tolerance seeking growth, but the negative expected return suggests that other investment opportunities may offer better long-term prospects.  Given the approaching overbought RSI and recent outperformance, it may be prudent to wait for a pullback before establishing or adding to a position.
